[Interpretation of the cardiovascular effects of a 38-degrees C. bath].

A. Cession-Fossion,J. Juchmes,Y. Hault,J. Lecomte,D. Tsalos

Abstract:

What problem does this paper attempt to address?

Endoscopic Treatment Can Be a Viable Therapeutic Option for Esophageal Gastrointestinal Stromal Tumors

Haojie Du,Longgui Ning,Hongtan Chen,Fengling Hu,Guodong Shan,Wenguo Chen,Guoqiang Xu

DOI: https://doi.org/10.1080/00365521.2021.2009024

2021-01-01

Scandinavian Journal of Gastroenterology

Abstract:Background Esophageal gastrointestinal stromal tumors(GISTs) are extremely rare. We sought to determine whether endoscopic treatment can be a viable therapeutic option for esophageal GISTs. Methods A total of 20 cases with histological diagnosis of esophageal GISTs were obtained from our center between 2008 and 2020. Data on the clinicopathological features and treatment were recorded. Results There were 9 males (45%) and 11 females (55%) in this study, with a median age of 56 years. The tumors preferentially occurred in the middle and lower parts of the thoracic esophagus (45 and 40%, respectively). The mean size of the tumors was 2.27 cm and mitotic index was no more than 5/50 high power field (HPF) in all patients. In this study, 11 patients received endoscopic treatment and nine patients underwent surgical resection. Tumors ranged from 0.6 to 4 cm in the endoscopic treatment patients and 0.5 to 7 cm in the surgical patients. There were no significant differences in gender, age, symptoms, tumor location, tumor size, mitotic index, and adjuvant imatinib therapy between the endoscopic treatment group and the surgery group (all p > .05). The Kaplan-Meier curve suggested that there was also no significant difference in disease-free survival between the two groups (p = .264). Conclusions Endoscopic treatment may be an option for the treatment of esophageal GISTs smaller than 5 cm with a mitotic index no more than 5/50 HPF.
Clinicopathological Characteristics of Gastrointestinal Mesenchymal Tumors and Diagnostic Value of Endoscopic Ultrasonography.

Feng Ji,Zi-Wei Wang,Li-Jun Wang,Jian-Wen Ning,Guo-Qiang Xu

DOI: https://doi.org/10.1111/j.1440-1746.2008.05322.x

2008-01-01

Journal of Gastroenterology and Hepatology

Abstract:Background and Aim: Gastrointestinal mesenchymal tumors (GIMTs) are tumors which arise from mesenchymal cells other than lymphocytes or epithelial cells and include gastrointestinal stromal tumors (GISTs), smooth muscle tumors, neurogenic tumors, fibroblast tumors, and liparomphalus. Here, we studied the clinicopathologic characteristics of GIMTs and determined the diagnostic value of endoscopic ultrasonography (EUS) in GIMTs.Methods: The morphological characteristics of 415 GIMT cases were observed using light microscopy. The expression of CD117, CD34, smooth muscle actin (SMA), S-100, and Ki-67 were detected using immunohistochemistry. EUS results were retrospectively analyzed in 76 cases.Results: Among the 415 GIMT cases, there were 229 GIST cases, 178 smooth muscle tumor cases, and eight neurogenic tumor cases. Diffuse strong expression of CD117 was observed in 202 (88.2%) GISTs and strong expression of CD34 was observed in 135 (59.0%) GISTs. SMA and S-100 expression was detected in smooth muscle tumors (leiomyomas/leiomyosarcoma) and neurogenic tumors, respectively. Of the 12 cases with GISTs, nine cases with positive ki-67 expression and accompanied with more mitosis were pathologically diagnosed as malignant GISTs. Most of the borderline and malignant tumors were found in male patients. EUS was 98.7% accurate in determining GIMT locations, 82.9% accurate in diagnosing GIMTs, and 80.3% accurate in differentiating benign from malignant tumors.Conclusions: GISTs, rather than leiomyomas, are the most common GIMTs. Immunohistochemical markers, such as CD117, CD34, SMA, and S-100, can differentiate GISTs from smooth muscle and neurogenic tumors. The expression of Ki-67 in patients with significant karyokinesis supports a malignant tumor diagnosis. EUS is an accurate method for detecting GIMTs and differentiating between benign and malignant tumors. Use of endoscopic ultrasound-guided fine-needle aspiration biopsies may enable clinicians to make more accurate diagnoses than currently used methods.
Diagnosis and Treatment of Duodenal Gastrointestinal Stromal Tumors

Haojie Du,Longgui Ning,Sha Li,Xinhe Lou,Hongtan Chen,Fengling Hu,Guodong Shan,Fenming Zhang,Guoqiang Xu

DOI: https://doi.org/10.14309/ctg.0000000000000156

2020-01-01

Clinical and Translational Gastroenterology

Abstract:OBJECTIVES: The diagnostic value of different noninvasive diagnostic modalities and the endoscopic ultrasoundguided fine-needle aspiration (EUS-FNA) reliability of duodenal gastrointestinal stromal tumors (GISTs) are ambiguous in the present studies. METHODS: Patients with a histopathological diagnosis of the primary duodenal GISTs between the years 2008 and 2018 were analyzed. Data on the treatment and clinicopathological features were recorded. Furthermore, the computed tomography (CT)/magnetic resonance imaging (MRI), EUS, and EUS-FNA results were collected and compared. RESULTS: A total of 142 patients were enrolled into the study. In all patients, the most common symptom was gastrointestinal bleeding (44.4%), followed by abdominal pain and bloating (27.5%). Duodenal GISTs were mostly located in the second duodenal portion (52.1%), followed by the first portion (19.0%). EUS had significantly higher sensitivity and positive predictive values than CT or MRI (P = 0.047 and P = 0.005, respectively). The EUS-FNA sensitivity of duodenal GISTs was also significantly higher than the conventional endoscopic biopsy (73.3% vs 33.3%, P = 0.006). A total of 131 patients underwent surgery, including limited resection or pancreaticoduodenectomy. The tumor size and postoperative complication rates were higher in patients who underwent pancreaticoduodenectomy (P = 0.001 and P < 0.001, respectively). DISCUSSION: The diagnostic value of EUS is significantly higher than that of CT and MRI for duodenal GISTs. The EUS-FNA can provide a histological diagnosis of duodenal GISTs in most cases.
Building contrast-enhanced CT-based models for preoperatively predicting malignant potential and Ki67 expression of small intestine gastrointestinal stromal tumors (GISTs)

Miao-Ping Zhu,Qiao-Ling Ding,Jian-Xia Xu,Chun-Yan Jiang,Jing Wang,Chao Wang,Ri-Sheng Yu

DOI: https://doi.org/10.1007/s00261-021-03040-9

IF: 2.4

2021-01-01

Abdominal Radiology

Abstract:Purpose To assess contrast-enhanced computed tomography (CE-CT) features for predicting malignant potential and Ki67 in small intestinal gastrointestinal stromal tumors (GISTs) and the correlation between them. Methods We retrospectively analyzed the pathological and imaging data for 123 patients (55 male/68 female, mean age: 57.2 years) with a histopathological diagnosis of small intestine GISTs who received CE-CT followed by curative surgery from May 2009 to August 2019. According to postoperatively pathological and immunohistochemical results, patients were categorized by malignant potential and the Ki67 index, respectively. CT features were analyzed to be associated with malignant potential or the Ki67 index using univariate analysis, logistic regression and receiver operating curve analysis. Then, we explored the correlation between the Ki67 index and malignant potential by using the Spearman rank correlation. Results Based on univariate and multivariate analysis, a predictive model of malignant potential of small intestine GISTs, consisting of tumor size ( p < 0.001) and presence of necrosis ( p = 0.033), was developed with the area under the receiver operating curve (AUC) of 0.965 (95% CI, 0.915–0.990; p < 0.001), with 91.53% sensitivity, 96.87% specificity, 96.43% PPV, 92.54% NPV, 94.31% diagnostic accuracy. For high Ki67 expression, a model made up of tumor size ( p = 0.051), presence of ulceration ( p = 0.054) and metastasis ( p = 0.001) may be the best predictive combination with an AUC of 0.785 (95% CI, 0.702–0.854; p < 0.001), 63.33% sensitivity, 76.34% specificity, 46.34% PPV, 86.59% NPV, 73.17% diagnostic accuracy. Ki67 index showed a moderate positive correlation with mitotic count ( r = 0.578, p < 0.001), a weak positive correlation with tumor size ( r = 0.339, p < 0.001) and with risk stratification ( r = 0.364, p < 0.001). Conclusion Features on CE-CT could preoperatively predict malignant potential and high Ki67 expression of small intestine GISTs, and Ki67 index may be a promising prognostic factor in predicting the prognosis of small intestine GISTs, independent of the risk stratification system.
Clinical analysis of endoscopic resection for submucosal tumors in the esophagogastric junction

闻瑜,陈毅鹏,单国栋,季峰

DOI: https://doi.org/10.3781/j.issn.1000-7431.2014.04.008

2014-01-01

Tumori

Abstract:Objective: To investigate the clinical application of endoscopic dissection technique for submucosal tumors (SMTs) in the esophagogastric junction (EGJ). Methods: A total of 43 cases of SMTs in the EGJ were treated by endoscopic resection in the Endoscopy Center of the First Affiliated Hospital, College of Medicine, Zhejiang University between January 2010 and October 2013. The clinical and histopathologic features, surgical approach, en bloc resection rate, complications, and postoperative follow-up information were evaluated. Results: There were 19 males and 24 females with a mean age of 52.0±11.0 years old. The en bloc resection rate was 100%. The mean lesion size was 27.81±19.51 mm. The mean procedure time was 66.97±30.53 minutes and the mean bleeding volume during operation was 4.65±12.12 mL. Perforations occurred in 4 patients, pneumoperitoneum in 2 patients, and esophago-mediastinal fistula in 1 patient. All of them were successfully managed with conservational therapy. One patient with severe pneumothorax was treated with thoracic drainage. Pathologic examination showed that the lesions were leiomyoma (n = 19), gastrointestinal stromal tumor (n = 14), unknown pathological type of spindle cell tumor (n = 5) and intermuscular lipoma (n = 3), and mucinous cystadenoma (n = 1). No local recurrence and distant metastasis were noted during the follow-up. Conclusion: Various endoscopic resection methods based on endoscopic submucosal dissection seem to be safe and effective for SMTs in the EGJ. DOI:10.3781/j.issn.1000-7431.2014.04.008
Double-balloon Enteroscopy in Small Bowel Diseases

Wenguo Chen,Siyu Guo,Hong Zhang,Ming Yang,Lin Liu,Min Yue,Guang-Wu Chen,Qing Gu,Hongyan Zhu,Guofan Xu,Lihua Chen

DOI: https://doi.org/10.1097/md.0000000000005104

IF: 1.6

2016-01-01

Medicine

Abstract:The aim of the study was to evaluate the diagnostic and therapeutic value of double-balloon entoroscopy (DBE) in small bowel diseases (SBDs) in China. A retrospective review of 674 consecutive patients who underwent DBE between January 2007 and November 2015 was conducted. Patients were divided into 3 groups by age, young group (<45 years), middle-aged group (45–65 years), and elderly group (>65 years). Data were collected with regard to demographics, clinical, endoscopic findings, complications, diagnostic yield, and management. A total of 729 DBE procedures were performed successfully in our series. More than 20 types of SBDs were found with the detection rate of 70.9%(517/729). The majority of patients were Crohn's disease (33.4%,225/674), followed by tumor (18.8%,127/674) and angioectasia (7.9%, 53/674). Endoscopic treatment was performed in 60 patients in which hemostasis (17,28.3%) and polypectomy (15,25%) were the predominant form of intervention used. Adverse events occurred in 6 patients (0.96%,6/729) including perforation, hemorrhage, aspiration pneumonia. No acute pancreatitis or other major complications occurred. Adenocarcinoma, GIST, and lymphoma were the most common tumor detected, the majority of tumors located in the jejunum (56.7%), The detection rate of angioectasia was also higher in the jejunum (54.7%),77.8% of Crohn's disease was located in the ileum. The positive rate of DBE in small bowel tumor and Crohn's disease were significantly higher than that of angioectasia (P<0.05). In young cohort, Crohn's disease (48.1%) was the most commonly diseases followed by tumor (10.4%) and nonspecific enteritis (7.1%). Yet in the elderly group, the majority of patients were tumor (27.6%); angioectasia (21.3%) was also detected frequently. The positive rate of capsule endoscopy was 75.44 %(202/268) which was a little high than DBE (67.9%, 182/268) (P > 0.05). The obscure gastrointestinal bleeding (OGIB) was the most common indication, and the diagnostic yield was 71.8%. DBE is a useful diagnostic and therapeutic tool with high clinical practice value for the investigation of SBDs. With growing experience of endoscopist, we believe that DBE must be kept in mind as the first-line modality for suspected SBDs.
The Analysis of Clinical Diagnosis for Small Intestinal Stromal Tumor: A Review of 74 Cases

Hong Zhao,Zhen Wu,Zhe Shen,Youming Li

DOI: https://doi.org/10.3760/cma.j.issn.0254-1432.2010.010.005

2010-01-01

Abstract:Objective To summarize the clinical characteristics of small intestinal stromal tumors(SIST), and evaluate the diagnostic values of various imaging or endoscope examinations for SIST. Methods From July 2004 to June 2009, 74 patients whose operation or endoscopy biopsy tissues pathologically confirmed SIST were collected. The clinical data, imageology including enteroclysis, abdominal ultrasound, spiral computered tomography (CT) and the double-balloon enteroscopy report of the patients were analyzed retrospectively. According to biological behavior, the SIST was divided into four risk degree such as extremely low risk, low risk, moderate risk and high risk. The correlation between pathologic characters and spiral CT feature was analyzed. Results The most predilection site of SIST was jejunum in 43 patients (58.1 %); secondarily duodenum in 17 cases (23%); and 10 cases (13.5%) in ileum. About 94.6 percent of patients (70/74) showed clinical signs, the most common symptom was gastrointestinal bleeding in 46 cases (67. 2 % ), abdominal pain in 23 cases (31.1%). Of various photogrammetry examinations and endoscopy, spiral CT has the highest diagnosis rate and diagnosis coincidence rate, which was 100% and 72. 1% respectively. Among the 74 SIST lesions, 14 cases were extremely low biological risk (18. 9 % ), 21 at low risk (28.4 % ), 15 at moderate risk (20. 3%) and 24 at high risk (32.4%). Spiral CT is helpful for the SIST risk diagnosis. Conclusions The onset of SIST was concealed and early diagnosis was very difficult. Spinal CT which could help to predict the tumor's risk degree and prognosis was noninvasive, convenient and reliable. Therefore, it could be the first choice for SIST examination at present. Key words: Gastrointestinal stromal tumor; Small intestinal stromal tumor; Spiral computed tomography
[Clinicopathological Features of Small Gastrointestinal Stromal Tumors].

Xiaodong Gao,Anwei Xue,Yong Fang,Ping Shu,Jiaqian Ling,Jianwei Hu,Yingyong Hou,Kuntang Shen,Jing Qin,Yihong Sun,Xinyu Qin

DOI: https://doi.org/10.3760/cma.j.issn.1671-0274.2015.04.010

2015-01-01

Abstract:OBJECTIVE:To investigate the clinicopathological features of small gastrointestinal stromal tumors(GISTs) and to evaluate the efficacy of endoscopic therapy for GISTs.METHODS:Clinicopathological and follow-up data of 418 patients with GISTs undergoing endoscopic therapy in the Zhongshan Hospital between January 2009 and July 2014 were analyzed retrospectively. All the cases were evaluated by the NIH risk classification and AIFP classification, and were grouped according to the tumor size and location. Nuclear atypia and mitotic count were used to evaluate the biological behavior of small GIST. Efficacy of endoscopic therapy was analyzed with follow-up data.RESULTS:Out of 418 patients, GISTs located in the esophagus was 14(3.3%), in the stomach 389(93.1%), in the duodenum 5(1.2%), in the rectum 10(2.4%). A total of 412(98.6%) patients were mainly spindle cells, and mitosis was not found in 320(76.5%) patients. In 389 small stomach GIST, 245(58.6%) were in fundic region. Cases were divided into four groups according to the size and the result revealed the bigger the size, the more the mitotic count. Nuclear atypia in the 1.5-1.9 cm group was significantly higher compared to other groups. Cases were divided into four groups according to the location and the result revealed the mitotic count was not associated to the location. While the nuclear atypia of stomach GIST was significantly higher than that of esophageal GIST and the nuclear atypia of rectum GIST was significantly higher than that of other positions. The median follow-up was 32(4-69) months. One case(gastric fundus GIST, >1.5 cm) presented local recurrence 23 months after operation and underwent endoscopic resection again. No recurrence or metastasis was found in other patients.CONCLUSIONS:Endoscopic resection technique is effective for small GISTs patients. The small GISTs with 0.4 cm diameter or less are often benign and should be followed up for long time. The small GISTs with 0.5 cm diameter or more possess the risk of malignancy, then surgical resection should be performed. Rectum small GISTs (except for 0.4 cm diameter or less) have worse biological behavior and should be removed.
Evaluation of Clinical Treatment of Primary Small Gastric Gastrointestinal Stromal Tumors:A Retrospec-Tive Single-Center Study

Wu Longyun,Peng Chunyan,Lyu Ying,Zhang Xiaoqi,Ling Tingsheng,Zhang Yiyang,Wang Lei,Yu Decai,Yang Tian,Shen Shanshan,Zou Xiaoping

DOI: https://doi.org/10.3760/cma.j.issn.1007-5232.2016.07.005

2016-01-01

Abstract:Objective To investigate the clinicopathologic features of primary small gastrointestinal stromal tumors ( GISTs ) and to evaluate the efficacy and safety of endoscopic resection based on ESD. Methods A retrospective analysis was performed in patients with pathologically proved small GISTs who un?derwent endoscopic resection( n=107) or surgery including open laparotomy or laparoscopic surgery( n=36) at Drum Tower Hospital from January 2012 to June 2015. The clinicopathologic features, treatment, adverse e?vents, and prognosis were evaluated. Results 1) A total of 143 patients were included in the study, 79?7%of whom with small GISTs were asymptomatic. Approximately 53?8% of GISTs occurred in the fundus of stom?ach. The median tumor size was 1?3 cm. Preoperative endoscopic ultrasonography ( EUS) revealed they were all classified as very low risk. Histological examinations showed that 112 ( 78?3%) patients were classified as very low risk, 24 (16?8%) as low risk, 4 (2?8%) as moderate risk and 3 (2?1%) as high risk. Subgroup a?nalysis suggested that the size of GISTs classified in moderate or high risk ranged from 1 to 2 cm. 2) The com?plete resection rate was close, 90?7% in endoscopy group and 100% in surgery group,respectively. Hospital stay was shorter in endoscopy group than that in surgery group (5 d VS 8 d, P<0?001). And the incidence of postoperative infection was lower in endoscopic group than in surgical group ( 0?9% VS 19?4%) . No recurrence or metastasis was detected, with the median follow?up period of 24 months. Conclusion In most of the cases, small gastric gastrointestinal stromal tumors occur in the fundus of stomach. Most patients with GISTs are asymptomatic, most of which are classified as very low risk or low risk. Preoperative EUS has a lim?ited value in evaluating invasive risk of small gastric GISTs. Endoscopic therapy based on ESD is feasible and safe in managing small gastric GISTs if complete resection can be assured.
Endoscopic and clinical character analysis of upper gastrointestinal tract gastrointestinal stromal tumor

Xuemei Wang,Yulan Liu

DOI: https://doi.org/10.3877/cma.j.issn.1674-0785.2015.16.014

2015-01-01

Abstract:Objective To investigate the gastroscopy, pathological and immunohistochemistry characteristics of upper gastrointestinal GIST, in order to improve the recognition and diagnosis of endoscopic doctor of the disease, reduce misdiagnosis and missed diagnosis. Methods Clinical manifestation, endoscopy, operation pathology and immunohistochemical data of 30 upper gastrointestinal GIST from January 2007 to April 2010 of Peking University People’s hospital were analyzed retrospectively. Results The main clinical manifestations of GIST included gastrointestinal hemorrhage in 11 cases (36.7%), abdominal pain in 6 cases (20%), abdominal discomfort in 4 cases (13.3%). Of the 30 cases of GIST, 12 (40%) were at the fundus, 7 (23.3%) were at the body. Endoscopically, in 30 GIST patients, 12 cases showed submucosal protuberant global or half-global lesions;7 cases were presented as submucosal protuberant with ulcer;4 cases were ulcer-like tumors;3 cases were submucosal protuberant with hollow on the top; 1 case was the submucosal surface erosion and proliferation; 2 cases were submucosal protuberant with erosion; 1 case was negative. 14 cases underwent endoscopic ultrasonography, most cases of the stromal tumors were from muscularis. Pathology revealed the typical stromal tumor features with cell in spindle shape. Immunohistochemical examination demonstrated CD117 positive rate was 96.7% (29/30), CD34 positive rate was 90% (29/30). Conclusion Most clinical manifestation of upper gastrointestinal GIST were gastrointestinal bleeding and abdominal pain, abdominal discomfort. Gastroscopic features of GIST were varied. Most were submucosal protuberant, 40%cases ofthe surface were smooth, 56.7%cases of surface with erosion or ulcer. A few cases of tumor, the surface present proliferation, it’s difficult to distinguish from cancer. The diagnosis rate of endoscopic ultrasound was satisfied.
The clinicopathologic characteristics of gastrointestinal mesenchymal tumor and the diagnostic value of endoscopic ultrasonography

NING Jian-wen,JI Feng,WANG Li-jun,宁建文,季峰,王丽君,许国强,厉有名

2006-01-01

Abstract:Objective To investigate the clinicopathologic characteristics of gastrointestinal mesenchymal tumor (GIMT), and to determine the diagnostic value of endoscopic ultrasonography (EUS) for it. Methods The morphologic characteristics of GIMT were observed by light microscopy in 265 cases. The expression of CD117, CD34, smooth muscle actin (SMA) , S-100 and Ki-67 were detected by Envision immunohistochemical method. EUS results were retrospectively analyzed in 32 cases. Results Among 265 GIMT cases, there were 146 cases of gastrointestinal stromal tumor (GIST) , 113 cases of leiomyoma or leiomyosarcoma, 6 cases of neurogenic tumour. In GIST, CD117 diffuse strong expression was found in 132 of 146 (90. 4%) cases, and CD34 predominant strong expression in 109 of 146 (74. 7%). SMA and S-100 expressions were found in mesenterium (retroperitoneum) and neurogenic tumour respectively. Expression of Ki-67 with significant karyokinesis was found in 7 of 9 cases with borderline or malignant profiles in histology. Most borderline and malignant tumors were found in male. The accuracies of EUS for determination of GIST location, the diagnosis of GIST and differentiation of benign from malignant were 96. 9% , 84. 4% and 71.9% respectively. Conclusions GIST rather than leiomyomas are the most common GIMT. Immunohistochemical markers such as CD117, CD34 and SMA, S -100 can differentiate GIST from leiomyomas and neurogenic tumors. The expression of Ki-67 with significant karyokinesis supports the diagnosis of malignant tumor. EUS plays an important role in detecting GIMT and in differentiating benign from malignant. Endoscopic ultrasound-guided fine-needle aspiration biopsy may be the better diagnostic choice in the future.
Comparative Clinical Features and Short-Term Outcomes of Gastric and Small Intestinal Gastrointestinal Stromal Tumours: a Retrospective Study

Zhengyang Yang,Feng Wang,Song Liu,Wenxian Guan

DOI: https://doi.org/10.1038/s41598-019-46520-1

IF: 4.6

2019-01-01

Scientific Reports

Abstract:Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal tumours of the gastrointestinal tract. Recent research has shown that small intestinal GISTs exhibit more aggressive features than gastric GISTs. To compare the clinical features of gastric and small intestinal GISTs for the further prediction of different prognoses, we conducted a retrospective study. 43 patients in the small intestine group and 97 in the gastric group were collected between January 2016 and December 2017. Data on demographics, preoperative lab results, clinicopathological results and surgical management were compared between groups. Significant elements were subsequently included in logistic regression analysis for further identification. The Kaplan-Meier method and log-rank test were used to calculate the relapse-free survival (RFS) rate and cumulative survival rate. Univariable analysis demonstrated that underlying disease, gastrointestinal (GI) bleeding, lymphocyte count, haemoglobin (Hb), albumin (ALB), platelet-to-lymphocyte ratio (PLR), thrombin time (TT), National Institutes of Health (NIH) category, Dog1, surgical procedure types and postoperative hospitalization were different between the two groups. Among these factors, logistic regression analysis identified that patients in small intestinal group exhibited significantly higher GI bleeding rate (p = 0.022), NIH category (p = 0.031), longer postoperative hospitalization time (p = 0.001) with lower TT value (p = 0.030) than those in gastric group. The log-rank test indicated that the location of the GIST (p = 0.022), GIST with GI bleeding (p = 0.027) and NIH category (p = 0.031) were independent prognostic predictors for poor outcome regarding RFS. Regarding cumulative survival, only the location of the GIST (p = 0.027) was an independent prognostic predictor for poor outcome. Thus, we concluded that small intestine GISTs were associated with lower TT, recurrent GI bleeding, advanced NIH category and extended postoperative hospitalization. Nevertheless, future multicentre prospective study are expected to validate our results.
Resection of GIST in the Duodenum and Proximal Jejunum: A Retrospective Analysis of Outcomes

Yi Huang,Guofeng Chen,Lele Lin,Xiaoli Jin,Muxing Kang,Yaoyi Zhang,Dike Shi,Kaibo Chen,Qingqu Guo,Li Chen,Dan Wu,Pintong Huang,Jian Chen

DOI: https://doi.org/10.1016/j.ejso.2019.05.002

IF: 4.037

2019-01-01

European Journal of Surgical Oncology

Abstract:Introduction: Gastrointestinal stromal tumors (GISTs), with a primary occurrence in the duodenum and proximal jejunum, are rare and treatment is poorly understood. This study aimed to evaluate the main factors influencing the prognosis of GIST resection in this complex anatomical structure. Materials and methods: This retrospective study included 47 patients who underwent surgery for primary GIST of the duodenum (20) and proximal jejunum (27) between 2012 and 2017. Perioperative clinical data as well as relapse and survival information were collected. Results: All patients underwent negative margin resection (R0) of duodenal and proximal jejunum GISTs. Complications occurred more frequently in treatment of duodenal GISTs than proximal jejunum GISTs (p = 0.003). GISTs in D3 (the 3rd portion of duodenum) were related to larger tumor size (p = 0.001), higher probability of severe complication rate (p = 0.042), longer hospital stays (p = 0.023) and fasting time (p = 0.020). More complications were found for patients with digestive reconstruction than limited resection (p = 0.010). Additionally, patients with a tumor mass larger than 5 cm or a mitotic index greater than 5 mitoses/50 HPFs showed poorer therapeutic outcomes. The 1- and 3-year overall survival was 97.9% and 86.1%, respectively and were not influenced by operation type (p = 0.061) or GIST position (p = 0.447). Conclusion: With negative operational margins, limited resection is a safe and feasible procedure for duodenal and proximal jejunum GIST patients and unnecessary digestive reconstruction should be avoided. Considering the severe complication rate, resection for GISTs in D3 should be performed with care. (C) 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Interventional digital subtraction angiography for small bowel gastrointestinal stromal tumors with bleeding.

Jing-xing Zhou,Yao-ting Chen,Dong Chen,Hong-liang Sun,Xiong-ying Jiang,J. Ni,Lin-Feng Xu,Jiang-hong Luo

DOI: https://doi.org/10.3748/wjg.v20.i47.17955

IF: 5.374

2014-12-21

World Journal of Gastroenterology

Abstract:AIM To retrospectively evaluate the diagnostic efficacy of interventional digital subtraction angiography (DSA) for bleeding small bowel gastrointestinal stromal tumors (GISTs). METHODS Between January 2006 and December 2013, small bowel tumors in 25 consecutive patients undergoing emergency interventional DSA were histopathologically confirmed as GIST after surgical resection. The medical records of these patients and the effects of interventional DSA and the presentation and management of the condition were retrospectively reviewed. RESULTS Of the 25 patients with an age range from 34- to 70-year-old (mean: 54 ± 12 years), 8 were male and 17 were female. Obscure gastrointestinal bleeding, including tarry or bloody stool and intermittent melena, was observed in all cases, and one case also involved hematemesis. Nineteen patients required acute blood transfusion. There were a total of 28 small bowel tumors detected by DSA. Among these, 20 were located in the jejunum and 8 were located in the ileum. The DSA characteristics of the GISTs included a hypervascular mass of well-defined, homogeneous enhancement and early developed draining veins. One case involved a complication of intussusception of the small intestine that was discovered during surgery. No pseudoaneurysms, arteriovenous malformations or fistulae, or arterial rupture were observed. The completely excised size was approximately 1.20 to 5.50 cm (mean: 3.05 ± 1.25 cm) in maximum diameter based on measurements after the resection. There were ulcerations (n = 8), erosions (n = 10), hyperemia and edema (n = 10) on the intra-luminal side of the tumors. Eight tumors in patients with a large amount of blood loss were treated with transcatheter arterial embolization with gelfoam particles during interventional DSA. CONCLUSION Emergency interventional DSA is a useful imaging option for locating and diagnosing small bowel GISTs in patients with bleeding, and is an effective treatment modality.

Medicine
Clinical analysis of gastrointestinal stromal tumor

Xue-mei WANG,Feng-li WU,Yu-lan LIU

DOI: https://doi.org/10.3760/cma.j.issn.1673-4777.2013.10.022

2013-01-01

Abstract:Objective To investigate the clinical features,pathological features and diagnosis of gastrointestinal stromal tumor(GIST) ; to improve early clinical diagnosis and to reduce misdiagnosis.Methods All 45 patients with GIST in our hospital who had gone through surgery and confirmed by pathology were retrospectively analyzed,which included clinical symptoms,laboratories,histopathology and immunohistochemistry.Results Of 45 GIST patients,there were 18 males and 27 females with age of 24-85 years old; the median age was 62 years old.Gastrointestinal bleeding and anemia were in 14 patients (31.1％) ; abdominal pain was in 9 cases (20.0％) and abdominal discomfort was in 7 cases (15.6％).Tumor locations:stomach in 25 cases (55.6％),small intestine in 15 cases(33.3％),rectum in 1 case,esophagus in 1 case and abdominal cavity 3 cases.The positive rates of CD 117 and CD34 in GIST patients were 97.8 ％ (44/45) and 79.5 ％ (35/44),respectively.The diagnosis rate of CT examinations of the abdomen was 78.4％ (29/37).The detection rate of gastroscopy for gastric GIST was 91.3％ (21/23).To duodenal bulb and descending GIST,the diagnosis rate of gastroscopy was 60.0％ (3/5).The diagnosis rate of endoscopic ultrasound was 100.0％ (10/10).Conclusions Most clinical manifestations of GIST are abdominal pain and melena.The positive rate of CD117 is high.The detection rate of gastroscopy for gastric and duodenal GIST is high,but the diagnosis rate is not high.The diagnosis rate of endoscopic ultrasound is good.
Clinicopathological Features and Prognosis of Small Gastric Gastrointestinal Stromal Tumors (Gists)

Mincong Wang,Anwei Xue,Wei Yuan,Xiaodong Gao,Min Fu,Yong Fang,Li Wang,Ping Shu,He Li,Yingyong Hou,Kuntang Shen,Yinghong Sun,Xinyu Qin

DOI: https://doi.org/10.1007/s11605-018-04070-3

2019-01-01

Journal of Gastrointestinal Surgery

Abstract:The aim of the present study was to evaluate the safety of endoscopic surgery, the clinicopathological features, and prognoses of small gastric gastrointestinal stromal tumors (GISTs). Small gastric GIST patients (diameter: 0.10–2.00 cm) resected endoscopically in Zhongshan Hospital were retrospectively identified and clinicopathological features and outcomes were collected. The relationship between clinicopathological characteristics and tumor recurrence was analyzed. Receiver operating characteristic (ROC) curve analysis was performed to determine the optimal tumor diameter for predicting malignant potential. All lesions were completely removed by endoscopy and En bloc resection was 98.5%. The most frequent location was the gastric fundus (60.3%) and the average diameter of all lesions was 1.20 cm (range: 0.10–2.00 cm). Mitoses were calculated as more than 5/50 HPF in 44 (6.8%) patients and nuclear atypia was moderate in 243 (37.5%) patients, severe in 1 (0.2%). Necrosis, mucosal infiltration, and vascular infiltration were detected in 8 (1.2%), 5 (0.7%), and 3 (0.5%) patients, respectively. Tumor size was positively correlated with mitotic index (P < 0.001) and nuclear atypia (P < 0.001). After a median follow-up of 54 months, four patients were confirmed local recurrence. ROC curve analysis identified 1.45 cm as the best cut-off value to predict malignant potential (95% CI: 0·694–0·774). Survival analysis showed that patients with tumor diameters larger than 1.45 cm were associated with more local recurrences after resection (P = 0.011). Endoscopic surgery is feasible and safe for small gastric GISTs, especially those in favorable locations. Small gastric GISTs bear a good prognosis as a whole but those with diameters larger than 1.45 cm should receive more intensive surveillance or undergo endoscopic surgery.
Predictors of the Difficulty for Endoscopic Resection of Gastric Gastrointestinal Stromal Tumor and Follow‐up Data

Wei Su,Min Wang,Danfeng Zhang,Yan Zhu,Minzhi Lv,Liang Zhu,Jie He,Hao Hu,Pinghong Zhou

DOI: https://doi.org/10.1111/jgh.15650

2022-01-01

Journal of Gastroenterology and Hepatology

Abstract:BACKGROUND AND AIM:Gastrointestinal stromal tumors (GISTs) are among the most common submucosal tumors in the stomach that require therapeutic intervention. We aim to identify the predictors of technical difficulty during endoscopic resection of gastric GIST and to investigate follow-up outcomes.METHODS:Patients with gastric GISTs were reviewed from June 2009 to June 2020 at Zhongshan Hospital. Clinical and pathological features, endoscopic procedure information, and follow-up data were collected and analyzed. A nomogram was developed and validated internally and externally.RESULTS:A total of 628 GISTs were finally analyzed. The difficulty was experienced in 66 cases. GISTs size (2-3 cm: OR 2.431 P = 0.018 and > 3 cm: OR 9.765 P < 0.001), invasion depth beyond submucosal (MP: OR 2.280, P = 0.038 and MP-ex: OR 4.295, P = 0.002), and lack of experience (OR 2.075, P = 0.016) were independent risk factors of difficulty. The nomogram prediction model showed a bias-corrected C-index value of 0.778 and acquired an area under curve (AUC) of 0.756 on the external validation cohort. At the cut-off of 0.15, the nomogram's negative predictive value (NPV) and accuracy (ACC) were 94.9% and 79.8% in identifying non-difficult GISTs. Follow-up results showed that only five GIST patients had local recurrence after endoscopic resection.CONCLUSIONS:Tumor size, invasion depth, and endoscopists' experience were risk factors for the difficulty of endoscopic GIST resection. Our nomogram provided a valuable tool for screening non-difficult GIST resection.
Comparison of Safety and Outcomes between Endoscopic and Surgical Resections of Small (≤ 5 cm) Primary Gastric Gastrointestinal Stromal Tumors.

Taohong Pang,Yan Zhao,Ting Fan,Qingqing Hu,Dekusaah Raymond,Shouli Cao,Weijie Zhang,Yi Wang,Bin Zhang,Ying Lv,Xiaoqi Zhang,Tingsheng Ling,Yuzheng Zhuge,Lei Wang,Xiaoping Zou,Qin Huang,Guifang Xu

DOI: https://doi.org/10.7150/jca.29443

IF: 3.9

2019-01-01

Journal of Cancer

Abstract:BACKGROUND AND AIMS:Endoscopic resection is increasingly performed for gastric gastrointestinal stromal tumors (GIST). However, the safety and outcomes remain elusive. We aimed in this retrospective study to compare operative complications and prognosis between endoscopically and surgically resected small (≤ 5 cm) GIST tumor groups. METHODS:In this single-center retrospective study, we compared demographics, clinical outcomes, and the R0 resection rate between the endoscopy (n =268) and surgery (n =141) groups. Only GIST tumors in size of ≤ 5.0 cm were recruited for this comparison study. RESULTS:Overall, the mean age of patients was 59.0 years (range: 31.0-83.0). The male-female ratio was 0.68. The most common site of GIST was, in the descending order, the gastric fundus (55%), corpus (27.6%), cardia (10.8%), and antrum (6.6%). Compared with the surgery group, GIST tumors in the endoscopy group were significantly smaller (1.69±0.9 cm, vs. 3.20±1.2 cm in the surgery group; P <0.001) in size; postoperative hospital stay was significantly shorter (4.66±1.5 days, vs. 8.11±5.0; P <0.001); post-resection time to first liquid diet was significantly shorter (1.94±1.1 days, vs. 4.63±2.6; P < 0.001); the incidence of operative and post-operative complications was significantly fewer (p < 0.05), and hospital costs were significantly lower (20115.4±5113.5¥, vs. 43378.4±16795.7¥; P < 0.001). The R0 resection rate was significantly lower in the endoscopy (93.3%) than in the surgery (99.3%) groups (P< 0.01). In the endoscopy group, 176 (65.7%) and 69 (25.7%) patients were found to be at very low and low risk of aggressiveness, respectively, in comparison to 27(19.2%) and 86 (61.0%) patients in the surgery group, respectively (P <0.001). Among 409 cases, 50 (12.2%) were found to be at intermediate or high risk of aggressiveness, 20 of which were treated with adjuvant imatinib therapy and but only 8/20 taking imatinib for 1 to 3 months because of side effects and high costs. No local or distant tumor recurrence was observed over an average of 33.5-month follow-ups. Two patients died of other disease in the surgery group. CONCLUSIONS:Endoscopic resection of selected small gastric GISTs (≤ 5cm) was feasible, safe, and associated with better intraoperative results and an equal postoperative course, compared to surgical resection.
Clinical Efficacy and Safety of Endoscopic Treatment of Gastrointestinal Stromal Tumors in the Stomach

Moon Kyung Joo,Jong-Jae Park,Yeon Ho Lee,Beom Jae Lee,Seong Min Kim,Won Shik Kim,Ah Young Yoo,Hoon Jai Chun,Sang Woo Lee

DOI: https://doi.org/10.5009/gnl210454

IF: 4.321

2023-02-15

Gut and Liver

Abstract:Background/Aims: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the stomach. We evaluated the clinical outcomes of endoscopic treatment for gastric GISTs.Methods: This is a single center, retrospective study that enrolled 135 cases of gastric subepithelial tumors (SETs) resected by endoscopic procedures and confirmed as GISTs by histopathology from March 2005 to July 2019. The immediate and long-term clinical outcomes were analyzed retrospectively.Results: The mean patient age was 57.9 years, and the mean tumor size was 2.1 cm. Of the tumors, 43.0% were located in the body, followed by the fundus (26.7%) and cardia (17.0%). Most tumors (85.2%) were resected by endoscopic submucosal dissection, followed by endoscopic mucosal resection (6.7%), submucosal tunneling endoscopic resection (5.9%), and endoscopic full-thickness resection (2.2%). Macroperforation occurred in 4.4% and microperforation in 6.7% of the cases. The R0 resection rate was 15.6%. However, the rate of complete resection by the endoscopic view was 90.4%, of which 54.8% of cases were in the very-low-risk group, followed by the low-risk group (28.1%), intermediate-risk group (11.9%), and high-risk group (5.2%). During 36.5 months of follow-up, recurrence was found in four (3.4%) of the 118 patients who were monitored for more than 6 months (low-risk group, 1/37 [2.7%]; intermediate-risk group, 2/11 [18.2%]; high-risk group, 1/6 [16.7%]).Conclusions: Endoscopic treatment of a GIST appears to be a feasible procedure in selected cases. However, additional surgery should be considered if the pathologic results correspond to intermediate- or high-risk groups.

gastroenterology & hepatology
Evaluation of Preoperative Endoscopic Ultrasonography for Diagnosis and Invasive Risk Assessment of Gastric Gastrointestinal Stromal Tumors:A Single-Center Retrospective Study

彭春艳,吕瑛,徐桂芳,凌亭生,王雷,余德才,沈珊珊,邹晓平,张晓琦

DOI: https://doi.org/10.3760/cma.j.issn.1007-5232.2015.06.002

2015-01-01

Abstract:Objective To evaluate preoperative endoscopic ultrasonography(EUS) for diagnosis and invasive risk assessment of gastric gastrointestinal stromal tumors (GISTs).Methods A total of 248 patients diagnosed as having gastric GISTs based on preoperative EUS and with established pathologic results at our institution were recruited to the study.The coincidence rates for gastric GISTs between preoperative EUS and pathologic results were calculated.Univariate and multivariate analyses were used to explore the possible predictors for the coincidence rates.EUS features were compared according to histological risk classification of very low/low risk malignant potential or intermediate/high risk malignant potential.Results The overall coincidence rate for gastric GISTs between EUS and pathologic results was 67.7％ (168/248).Univariate analysis showed that tumor diameter,mucosal bridge,heterogeneity,and calcification were significantly correlated with the coincidence rate for gastric GISTs between preoperative EUS and pathologic results.Multivariate analysis indicated that heterogeneity (OR =2.53,95 ％ CI:1.23-5.18,P =0.011) and calcification (OR =2.25,95％ CI:1.34-6.56,P =0.045) were the independent factors for the coincidence rate.A total of 168 patients were divided into four groups according to histological risk:very low risk (n =63),low risk (n =62),intermediate risk(n =26),and high risk(n =17).Gastric GISTs with heterogeneity,mucosal ulceration,and calcification on EUS suggested higher risk GISTs.Multivariate analysis indicated that only tumor diameter(P ＜ 0.000 1) could predict malignant potential of gastric GISTs.Conclusion Preoperative EUS plays an role in diagnosing and evaluating of invasive risk for gastric GISTs,which might aid the clinical management of gastric GISTs.

[Interpretation of the cardiovascular effects of a 38-degrees C. bath].

Endoscopic Treatment Can Be a Viable Therapeutic Option for Esophageal Gastrointestinal Stromal Tumors

Clinicopathological Characteristics of Gastrointestinal Mesenchymal Tumors and Diagnostic Value of Endoscopic Ultrasonography.

Diagnosis and Treatment of Duodenal Gastrointestinal Stromal Tumors

Building contrast-enhanced CT-based models for preoperatively predicting malignant potential and Ki67 expression of small intestine gastrointestinal stromal tumors (GISTs)

Clinical analysis of endoscopic resection for submucosal tumors in the esophagogastric junction

Double-balloon Enteroscopy in Small Bowel Diseases

The Analysis of Clinical Diagnosis for Small Intestinal Stromal Tumor: A Review of 74 Cases

[Clinicopathological Features of Small Gastrointestinal Stromal Tumors].

Evaluation of Clinical Treatment of Primary Small Gastric Gastrointestinal Stromal Tumors:A Retrospec-Tive Single-Center Study

Endoscopic and clinical character analysis of upper gastrointestinal tract gastrointestinal stromal tumor

The clinicopathologic characteristics of gastrointestinal mesenchymal tumor and the diagnostic value of endoscopic ultrasonography

Comparative Clinical Features and Short-Term Outcomes of Gastric and Small Intestinal Gastrointestinal Stromal Tumours: a Retrospective Study

Resection of GIST in the Duodenum and Proximal Jejunum: A Retrospective Analysis of Outcomes

Interventional digital subtraction angiography for small bowel gastrointestinal stromal tumors with bleeding.

Clinical analysis of gastrointestinal stromal tumor

Clinicopathological Features and Prognosis of Small Gastric Gastrointestinal Stromal Tumors (Gists)

Predictors of the Difficulty for Endoscopic Resection of Gastric Gastrointestinal Stromal Tumor and Follow‐up Data

Comparison of Safety and Outcomes between Endoscopic and Surgical Resections of Small (≤ 5 cm) Primary Gastric Gastrointestinal Stromal Tumors.

Clinical Efficacy and Safety of Endoscopic Treatment of Gastrointestinal Stromal Tumors in the Stomach

Evaluation of Preoperative Endoscopic Ultrasonography for Diagnosis and Invasive Risk Assessment of Gastric Gastrointestinal Stromal Tumors:A Single-Center Retrospective Study